InspireMD, Inc.

NSPR

InspireMD, Inc.

NSPR

Insider Sentiment (TTM):

Last Purchase:2026-05-27Last Sale:2026-05-19Shares Purchased (TTM):262,050Shares Sold (TTM):24,778

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:22,423,562Shares Outstanding:83,801,839Institutional Ownership Pct.:26.76%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	15	11	9	63	12	12	19	16	28	9	10	14
Marketable Securities Current	15	30	45	-	8	14	16	25	19	25	29	29
Accounts Receivable Net C…
Accounts Receivable Net Current	2	2	2	2	2	2	2	2	1	1	2	1
Nontrade Receivables Current	1	0	0	0	0	1	1	1	0	0	1	0
Assets Current
Assets Current	37	49	61	70	25	32	41	46	52	39	44	47
Prepaid Expense Current	1	1	1	1	1	1	1	1	1	1	1	0
Inventory Net	3	3	3	4	3	3	3	2	2	2	2	2
Deposits Assets Noncurrent	0	0	0	0	0	0	0	-	-	-	-	-
Property Plant And Equipment Net	4	4	4	3	3	3	2	2	2	1	1	1
Operating Lease Right Of Use Asset	2	3	3	3	0	2	2	1	1	1	1	2
Assets Noncurrent
Assets Noncurrent	8	8	8	8	8	7	6	4	4	4	3	3
Defined Benefit Plan Assets For Plan Benefits Nonc…	1	1	1	1	1	1	1	1	1	1	1	1
Assets	45	56	69	78	33	39	47	50	56	42	48	50
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accr…
Accounts Payable Trade Current	2	2	1	2	2	2	1	1	1	1	1	1
Accounts Payable Other Current	8	7	9	9	8	6	6	6	6	4	5	4
Liabilities Current	10	9	11	11	9	7	8	7	7	5	6	5
Operating Lease Liability Noncurrent	2	2	2	2	3	2	2	1	1	1	1	1
Pension And Other Postretirement Defined Benefit P…	2	1	1	1	2	1	1	1	1	1	1	1
Liabilities Noncurrent
Liabilities Noncurrent	3	3	3	4	4	3	3	2	2	2	2	2
Liabilities	13	13	14	14	13	10	11	9	9	7	8	7
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	362	360	357	355	298	293	290	286	283	264	261	259
Stockholders Equity	32	44	55	64	20	28	36	41	47	35	40	43
Retained Earnings Accumulated Deficit	-330	-316	-302	-291	-278	-265	-254	-244	-236	-229	-222	-216
Liabilities And Stockholders Equity	45	56	69	78	33	39	47	50	56	42	48	50
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	250	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	47	47	44	42	33	30	27	26	25	23	22	21
Shares Outstanding	47	47	44	42	33	30	27	26	25	23	22	21

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-20.69%	-37.93%	-41.38%	-	-	-	-	-	-	-	-	-
2025	-1.54%	-11.92%	-6.54%	-8.61%	-10.49%	-15.36%	11.90%	10.71%	-5.95%	-27.93%	-35.75%	-50.84%
2024	12.08%	-0.42%	23.75%	-7.09%	-7.09%	-17.23%	28.57%	13.87%	8.40%	-6.05%	-3.91%	-8.90%
2023	-	-	-	-	-	-	-27.84%	-15.87%	-11.98%	-9.89%	-23.95%	-3.42%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.80	5.15	5.74	6.51	2.81	4.36	5.28	6.39	7.44	7.90	7.34	9.96
Quick Ratio	3.40	4.70	5.30	6.09	2.37	3.86	4.80	5.87	7.02	7.30	6.89	9.47
Working Capital	26.98M	39.15M	50.76M	59.58M	16.40M	24.78M	32.84M	39.13M	44.88M	33.63M	38.14M	42.04M
Leverage & Debt
Debt to Equity	0.42	0.29	0.26	0.22	0.65	0.36	0.30	0.22	0.19	0.20	0.21	0.16
Debt Ratio	0.29	0.23	0.20	0.18	0.39	0.27	0.23	0.18	0.16	0.17	0.17	0.14
Efficiency & Turnover
Asset Turnover TTM	0.28	0.23	0.15	0.12	0.16	0.17	0.15	0.14	0.12	0.21	0.17	0.14
Days Sales Outstanding TTM	57.37	66.64	76.02	81.90	74.88	71.86	87.90	68.90	77.17	73.37	83.47	73.77
Receivables Turnover TTM	6.36	5.48	4.80	4.46	4.87	5.08	4.15	5.30	4.73	4.97	4.37	4.95
Per Share Metrics
Diluted EPS TTM	-0.62	-0.61	-0.76	-0.63	-0.81	-0.72	-0.76	-0.58	-0.71	-0.66	-0.82	-0.57
Free Cash Flow Per Share TTM	-0.50	-0.48	-0.57	-0.46	-0.61	-0.54	-0.55	-0.43	-0.52	-0.50	-0.69	-0.46
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	18.05%	28.06%	29.50%	24.91%	21.06%	21.43%	21.49%	22.61%	23.85%	26.65%	29.12%	27.42%
Operating Profit Margin TTM	-494.03%	-480.57%	-552.56%	-602.87%	-598.75%	-534.35%	-478.00%	-439.00%	-412.99%	-373.26%	-340.74%	-370.59%
Net Profit Margin TTM	-484.11%	-472.98%	-543.33%	-593.89%	-585.64%	-514.29%	-456.63%	-413.96%	-388.67%	-350.35%	-320.97%	-353.86%
Growth Metrics
Net Revenue Growth (1Y)	53.42%	54.38%	28.11%	14.04%	7.60%	8.49%	12.96%	24.70%	22.86%	23.91%	20.00%	-1.00%
Net Income Growth (1Y)	26.83%	41.98%	52.43%	63.62%	62.13%	59.26%	60.70%	45.88%	36.44%	24.23%	7.71%	9.09%
EPS Growth (1Y)	-23.59%	-15.30%	-0.64%	7.72%	14.04%	9.08%	-6.99%	2.50%	-19.86%	-70.64%	-65.06%	-74.84%
Valuation Metrics
P/E TTM	-1.13	-2.66	-2.35	-3.83	-2.80	-3.72	-3.45	-4.59	-3.51	-3.58	-3.42	-5.74
P/B TTM	1.88	3.13	2.07	2.76	5.72	4.74	3.06	3.13	1.92	2.31	1.73	2.57
P/S TTM	5.47	12.59	12.75	22.76	16.39	19.14	15.73	19.00	13.66	12.53	10.99	20.32
Market Cap	59.26M	136.60M	114.50M	177.05M	115.78M	134.48M	110.27M	129.63M	89.69M	81.16M	68.19M	111.13M
Enterprise Value	44.11M	125.23M	105.56M	113.65M	104.27M	122.10M	91.36M	113.81M	61.31M	71.77M	58.55M	97.29M
Calculated Values
Free Cash Flow TTM	-42.46M	-40.15M	-36.77M	-34.08M	-31.24M	-27.16M	-23.27M	-20.60M	-18.62M	-17.16M	-16.76M	-15.66M
Net Debt	-15.15M	-11.36M	-8.94M	-63.40M	-11.51M	-12.38M	-18.92M	-15.82M	-28.39M	-9.39M	-9.64M	-13.84M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-27Purchase

Owner: Stuka, Paul

Title: -

Shares: 20,000

Price/Share: $0.88

Value: $17,600.00

Shares Owned: 667,871

Relationship: Director

Ownership: Direct

2026-05-19Sale

Owner: Gleason, Shane Thomas

Title: Chief Commercial Officer

Shares: 22,778

Price/Share: $1.01

Value: $23,005.78

Shares Owned: 1,053,882

Relationship: Officer

Ownership: Direct

2026-05-14Purchase

Owner: Stuka, Paul

Title: -

Shares: 5,000

Price/Share: $1.15

Value: $5,750.00

Shares Owned: 647,871

Relationship: Director

Ownership: Direct

2026-05-12Purchase

Owner: Slosman, Marvin

Title: CEO and President

Shares: 21,000

Price/Share: $1.20

Value: $25,200.00

Shares Owned: 3,556,658

Relationship: Director,Officer

Ownership: Direct

2026-05-11Purchase

Owner: Stuka, Paul

Title: -

Shares: 10,000

Price/Share: $1.19

Value: $11,900.00

Shares Owned: 632,871

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-27	Stuka, Paul	Director	-	Direct	Purchase	20,000	0.88	$17,600.00	667,871	4
2026-05-19	Gleason, Shane Thomas	Officer	Chief Commercial Officer	Direct	Sale	22,778	1.01	$23,005.78	1,053,882	4
2026-05-14	Stuka, Paul	Director	-	Direct	Purchase	5,000	1.15	$5,750.00	647,871	4
2026-05-12	Slosman, Marvin	Director,Officer	CEO and President	Direct	Purchase	21,000	1.20	$25,200.00	3,556,658	4
2026-05-11	Stuka, Paul	Director	-	Direct	Purchase	10,000	1.19	$11,900.00	632,871	4/A
2026-05-07	Ward, Scott R.	Director	-	Direct	Purchase	73,255	1.15	$84,243.25	237,096	4
2026-05-07	Roubin, Gary S	Director	-	Direct	Purchase	90,000	1.18	$106,200.00	834,478	4
2026-05-07	Stuka, Paul	Director	-	Direct	Purchase	6,378	1.15	$7,334.70	531,599	4
2026-02-02	Gleason, Shane Thomas	Officer	Chief Commercial Officer	Direct	Sale	2,000	1.60	$3,200.00	1,139,177	4
2025-12-09	Stuka, Paul	Director	-	Direct	Purchase	5,073	1.81	$9,182.13	391,628	4
2025-12-09	Stuka, Paul	Director	-	Direct	Purchase	2,710	1.81	$4,905.10	391,628	4/A
2025-12-05	Stuka, Paul	Director	-	Direct	Purchase	5,073	1.86	$9,435.78	388,918	4
2025-12-04	Stuka, Paul	Director	-	Direct	Purchase	10,130	1.85	$18,740.50	383,845	4
2025-11-12	Stuka, Paul	Director	-	Direct	Purchase	13,431	1.62	$21,758.22	373,715	4
2025-07-30	Stuka, Paul	Director	-	Indirect	Purchase	20,661	2.42	$49,999.62	444,195	4
2025-07-30	Roubin, Gary S	Director	-	Direct	Purchase	41,322	2.42	$99,999.24	608,425	4
2025-07-30	Kester, Thomas J	Director	-	Direct	Purchase	30,991	2.42	$74,998.22	420,758	4
2025-07-30	Slosman, Marvin	Director,Officer	CEO and President	Direct	Purchase	10,330	2.42	$24,998.60	2,420,866	4
2023-11-30	Roubin, Gary S	Director	-	Direct	Purchase	50,000	2.53	$126,500.00	438,902	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

26.76%

Inst. Shares: 22,423,562

Shares Outstanding: 83,801,839

2025-12-31

35.38%

Inst. Shares: 22,757,576

Shares Outstanding: 64,325,810

2025-09-30

30.59%

Inst. Shares: 22,472,478

Shares Outstanding: 73,466,501

2025-06-30

27.57%

Inst. Shares: 14,061,920

Shares Outstanding: 51,003,900

2025-03-31

25.60%

Inst. Shares: 12,799,621

Shares Outstanding: 49,993,509

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	22,423,562	83,801,839	26.76%
2025-12-31	22,757,576	64,325,810	35.38%
2025-09-30	22,472,478	73,466,501	30.59%
2025-06-30	14,061,920	51,003,900	27.57%
2025-03-31	12,799,621	49,993,509	25.60%
2024-12-31	12,710,919	41,928,360	30.32%
2024-09-30	12,390,604	48,369,412	25.62%
2024-06-30	11,909,807	35,877,926	33.20%
2024-03-31	10,123,324	34,242,976	29.56%
2023-12-31	10,280,259	24,268,181	42.36%
2023-09-30	8,742,676	33,984,953	25.73%
2023-06-30	8,038,964	21,074,187	38.15%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

InspireMD, Inc. (NSPR) — SEC Financial Statements & Analysis

InspireMD, Inc. (NSPR) is a surgical & medical instruments & apparatus company, incorporated in DE. InspireMD, Inc. trades on Nasdaq as: NSPR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), InspireMD, Inc. reported a 53.42% year-over-year revenue growth, a Gross Profit Margin of 18.05% (TTM), a Debt-to-Equity ratio of 0.42x, a Price-to-Sales (P/S) ratio of 5.47x (TTM), a Price-to-Book (P/B) ratio of 1.88x (TTM), at a market cap of $59.26M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 53.42%
Gross Profit Margin TTM: 18.05%
Debt To Equity: 0.42x
P/S TTM: 5.47x
P/B TTM: 1.88x
Market Cap: $59.26M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is InspireMD, Inc. in?

InspireMD, Inc. (NSPR) operates in the Surgical & Medical Instruments & Apparatus industry.

What is NSPR's market cap?

InspireMD, Inc. (NSPR) has a market capitalization of $59.26M as of 2026-06-30.

What exchange does NSPR trade on?

InspireMD, Inc. (NSPR) trades on the Nasdaq.

Where is InspireMD, Inc. incorporated?

InspireMD, Inc. is incorporated in DE.

InspireMD, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

InspireMD, Inc. (NSPR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

InspireMD, Inc. (NSPR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.